In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

""Thailand's Low-Cost Generic Drugs Scheme A Boon For Poor (Thailand)

This article was originally published in PharmAsia News

Executive Summary

Activists have praised Thailand for its recent decision to issue compulsory licenses for life-saving medications. These compulsory licenses temporarily remove patent protections on brand-name drugs. By doing so, Thailand will be able to import and produce less-expensive versions of these medications. Activists say Thailand is setting an example for developing nations who want to ensure quality healthcare for their citizens. Other countries, including Brazil, have already taken steps to institute similar programs. Major pharmaceutical companies have protested the Thai government's move arguing it is a violation of their intellectual property rights. However, experts say Thailand's actions are within the bounds of international law. So far, the country has issued compulsory licenses for the heart medication Plavix as well as AIDS treatments Kaletra and Efavirenz. Already generic versions of these drugs are flowing in from major Indian generics producers. In addition, the Thai government has announced it is also considering suspending patents for four cancer treatments. (Click here for more
UsernamePublicRestriction

Register

SC065816

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel